R. Y. Kanoun, “Role of measurable residual disease quantified by 4 to 6 color flow cytometry before allogeneic hematopoietic stem cell transplantation for high-risk Philadelphia-negative acute lymphoblastic leukemia”, J Stem Cell Ther Transplant, vol. 7, no. 1, pp. 016–023, Apr. 2023.